Last reviewed · How we verify

NCT05605691

Post-Market Lower Eyelid Treatment With Renuvion in Greece

Completed NA Results posted Last updated 26 March 2025
What this trial tests

NA trial testing Renuvion APR System in Skin Laxity in 16 participants. Completed in 5 March 2024.

Timeline
11 October 2022
Primary endpoint
5 March 2024
5 March 2024

Quick facts

Lead sponsorApyx Medical
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment16
Start date11 October 2022
Primary completion5 March 2024
Estimated completion5 March 2024
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Apyx Medical — full company profile →

Who can join

Adults 18 to 75, any sex, with Skin Laxity. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Day 180 Number of Participants With Improvement in Lower Eyelid Area as Determined by a Masked, Qualitative Assessment. Primary · 180-Day

Improvement in the lower eyelid area as determined by a masked, qualitative assessment of photographs at 180-days post-treatment compared to baseline by blinded independent reviewers. Improvement will be assessed based on photographs taken at all visits using the site's 2D camera system.

GroupValue95% CI
Renuvion APR System Treatment5
Day 90 Number of Participants With Improvement in the Lower Eyelid Area as Determined by a Masked, Qualitative Assessment. Secondary · 90-Day

Improvement in the lower eyelid area as determined by a masked, qualitative assessment of photographs at 90-days post-treatment compared to baseline by blinded independent reviewers. Improvement will be assessed based on photographs taken at all visits using the site's 2D camera system.

GroupValue95% CI
Renuvion APR System Treatment8
Snap-Back Test Grade Analysis of Change From Baseline to Day 30 Secondary · 30-Day

This test provides relative lower lid laxity. In normal lids, the skin snaps-back to the original position immediately; the longer it takes, the more laxity is present. To perform the snap-back test, pull the lower lid away and down from globe for several seconds and wait to see how long it returns to the original position without the subject blinking. Grade 0 (Normal lid that returns to position immediately on release), Grade I (Approx 2-3 seconds to return to original position), Grade II (4-5 seconds to return to original position), Grade III (\>5 seconds but does return to original position

GroupValue95% CI
Renuvion APR System Treatment15
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Snap-Back Test Grade Analysis of Change From Baseline to Day 90 Secondary · 90-Day

This test provides relative lower lid laxity. In normal lids, the skin snaps-back to the original position immediately; the longer it takes, the more laxity is present. To perform the snap-back test, pull the lower lid away and down from globe for several seconds and wait to see how long it returns to the original position without the subject blinking. Grade 0 (Normal lid that returns to position immediately on release), Grade I (Approx 2-3 seconds to return to original position), Grade II (4-5 seconds to return to original position), Grade III (\>5 seconds but does return to original position

GroupValue95% CI
Renuvion APR System Treatment15
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Snap-Back Test Grade Analysis of Change From Baseline to Day 180 Secondary · 180-Day

This test provides relative lower lid laxity. In normal lids, the skin snaps-back to the original position immediately; the longer it takes, the more laxity is present. To perform the snap-back test, pull the lower lid away and down from globe for several seconds and wait to see how long it returns to the original position without the subject blinking. Grade 0 (Normal lid that returns to position immediately on release), Grade I (Approx 2-3 seconds to return to original position), Grade II (4-5 seconds to return to original position), Grade III (\>5 seconds but does return to original position

GroupValue95% CI
Renuvion APR System Treatment15
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Medical Canthal Laxity Test Analysis of Change From Baseline to Day 30 Secondary · 30-Day

This test provides medial canthal laxity by means of measuring displacement. The greater the distance, the more the laxity. To perform the medial canthal laxity test, pull the lower lid laterally away from the medial canthus and measure displacement of medial punctum. Grade 0 (\<2mm displacement), Grade I (approx 2mm displacement), Grade II (approx 3mm displacement), Grade III (\>3mm displacement), Grade IV (does not return to baseline after release and blinking).

GroupValue95% CI
Renuvion APR System Treatment13
Renuvion APR System Treatment2
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Medical Canthal Laxity Test Analysis of Change From Baseline to Day 90 Secondary · 90-Day

This test provides medial canthal laxity by means of measuring displacement. The greater the distance, the more the laxity. To perform the medial canthal laxity test, pull the lower lid laterally away from the medial canthus and measure displacement of medial punctum. Grade 0 (\<2mm displacement), Grade I (approx 2mm displacement), Grade II (approx 3mm displacement), Grade III (\>3mm displacement), Grade IV (does not return to baseline after release and blinking).

GroupValue95% CI
Renuvion APR System Treatment15
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Medical Canthal Laxity Test Analysis of Change From Baseline to Day 180 Secondary · 180-Day

This test provides medial canthal laxity by means of measuring displacement. The greater the distance, the more the laxity. To perform the medial canthal laxity test, pull the lower lid laterally away from the medial canthus and measure displacement of medial punctum. Grade 0 (\<2mm displacement), Grade I (approx 2mm displacement), Grade II (approx 3mm displacement), Grade III (\>3mm displacement), Grade IV (does not return to baseline after release and blinking).

GroupValue95% CI
Renuvion APR System Treatment15
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Lateral Canthal Laxity Test Analysis of Change From Baseline to Day 30 Secondary · 30-Day

This test provides lateral canthal laxity by means of measuring displacement. The greater the distance, the more the laxity. To perform the lateral canthal laxity test, pull the lower lid medially away from the lateral canthus and measure displacement of lateral canthal corner. Grade 0 (\<2mm displacement), Grade I (2-4mm displacement), Grade II (4-6mm displacement), Grade III (\>6mm displacement), Grade IV (does not return to baseline after release and blinking).

GroupValue95% CI
Renuvion APR System Treatment13
Renuvion APR System Treatment2
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Lateral Canthal Laxity Test Analysis of Change From Baseline to Day 90 Secondary · 90-Day

This test provides lateral canthal laxity by means of measuring displacement. The greater the distance, the more the laxity. To perform the lateral canthal laxity test, pull the lower lid medially away from the lateral canthus and measure displacement of lateral canthal corner. Grade 0 (\<2mm displacement), Grade I (2-4mm displacement), Grade II (4-6mm displacement), Grade III (\>6mm displacement), Grade IV (does not return to baseline after release and blinking).

GroupValue95% CI
Renuvion APR System Treatment15
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Lateral Canthal Laxity Test Analysis of Change From Baseline to Day 180 Secondary · 180-Day

This test provides lateral canthal laxity by means of measuring displacement. The greater the distance, the more the laxity. To perform the lateral canthal laxity test, pull the lower lid medially away from the lateral canthus and measure displacement of lateral canthal corner. Grade 0 (\<2mm displacement), Grade I (2-4mm displacement), Grade II (4-6mm displacement), Grade III (\>6mm displacement), Grade IV (does not return to baseline after release and blinking).

GroupValue95% CI
Renuvion APR System Treatment15
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Renuvion APR System Treatment0
Subject Modified Global Aesthetic Improvement Scale (GAIS) Secondary · 90-Day

The subject will grade the overall improvement of treatment area as very much improved, much improved, improved, no change, worse, much worse, and very much worse.

GroupValue95% CI
Renuvion APR System Treatment14
Renuvion APR System Treatment1
Renuvion APR System Treatment0
Renuvion APR System Treatment0

Adverse events — posted to ClinicalTrials.gov

Time frame: Through Day 180 follow-up visit.. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Renuvion APR System Treatment
Serious: 0/16 (0%)
Deaths: 0/16
Other adverse events (3 terms — click to expand)

ReactionSystemRenuvion APR System Treatm…
Bruise (ETE)Skin and subcutaneous tissue disorders
Edema (ETE)Skin and subcutaneous tissue disorders
Contact DermatitisSkin and subcutaneous tissue disorders

Data from ClinicalTrials.gov NCT05605691 adverse events section.

Sponsor's own description

This is a prospective, multi-center, non-randomized, single-arm study of up to 15 subjects treated with the Renuvion APR System. Subjects will receive treatment with the Renuvion APR System in the lower periorbital area on both sides of the face.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Renuvion APR System

Trials testing the same drug.

Other recruiting trials for Skin Laxity

Currently open trials in the same condition.

Other Apyx Medical trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05605691.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing